Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Dr Reddys Laboratories (RDY) over the last 14 years, with Q4 2025 value amounting to $769.6 million.

  • Dr Reddys Laboratories' Long-Term Investments changed N/A to $769.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $769.6 million, marking a year-over-year change of. This contributed to the annual value of $122.0 million for FY2025, which is 14400.0% up from last year.
  • As of Q4 2025, Dr Reddys Laboratories' Long-Term Investments stood at $769.6 million.
  • Dr Reddys Laboratories' Long-Term Investments' 5-year high stood at $769.6 million during Q4 2025, with a 5-year trough of -$3.8 million in Q3 2024.
  • Its 5-year average for Long-Term Investments is $308.1 million, with a median of $245.7 million in 2021.
  • Its Long-Term Investments has fluctuated over the past 5 years, first skyrocketed by 17352954744.03% in 2023, then tumbled by 10055.63% in 2024.
  • Over the past 5 years, Dr Reddys Laboratories' Long-Term Investments (Quarter) stood at $207.9 million in 2021, then surged by 157.17% to $534.8 million in 2022, then increased by 27.23% to $680.4 million in 2023, then tumbled by 100.56% to -$3.8 million in 2024, then soared by 20433.27% to $769.6 million in 2025.
  • Its last three reported values are $769.6 million in Q4 2025, $686.6 million for Q3 2025, and -$595920.3 during Q2 2025.